#United States #Tampa #Inspirata AI #Cancer Registry #ONCO Inc.

Inspirata AI: Revolutionizing Cancer Registry Operations

In a significant move that marks a new era in cancer care management, Inspirata has announced its rebranding to Inspirata AI. This change is not merely cosmetic; it represents two decades of pioneering innovation in cancer registry practices and the integration of advanced AI technologies that elevate the capabilities of healthcare organizations.

The new branding comes alongside the announcement of a robust partnership with ONCO Inc., reinforcing their commitment to enhancing cancer casefinding, data abstraction, and comprehensive reporting capabilities. This collaboration aims to streamline cancer registry operations across multiple countries, including the United States, Canada, and Australia.

Advancements in Cancer Casefinding and Reporting

At the heart of Inspirata AI’s evolution lies a proprietary solution powered by a native AI and Natural Language Processing (NLP) engine. This innovative platform utilizes FHIR-based integrations and connectivity with various clinical systems, including AP-LIS and radiology, to identify and report cancer cases in real time. By analyzing source documents as they are created, the system ensures timely and accurate case identification, significantly optimizing workflow for cancer registries.

Satish Sanan, CEO of Inspirata AI, emphasized the monumental engineering investment that has facilitated this transition. “Our rebranding symbolizes the hard work and technological advancements that have culminated in this innovative platform, providing our clients with the first comprehensive end-to-end cancer registry solution available,” he stated.

The integration of ONCO’s workflow tools complements Inspirata AI's systems, creating a seamless, automated solution for cancer programs. This collaboration not only enhances data abstraction and reporting but also eliminates redundant data entry, reducing the administrative burden often faced by registries.

Accuracy and Efficiency: A New Standard

With an impressive 99% accuracy rate, Inspirata AI promises not just improved efficiency but a transformation in how healthcare organizations view cancer registries. Traditionally seen as cost centers, these operations can now serve as strategic assets that facilitate growth in oncology service lines, enhance patient retention rates, and prepare organizations for accreditation readiness.

Jim Hendrickson, Co-CEO of ONCO Inc., voiced his enthusiasm about the partnership. “The synergy created by combining our workflow expertise with Inspirata AI’s advanced technology allows us to redefine the cancer registry landscape. Our collaborative efforts deliver timely access to accurate clinical data, positioning our clients for strategic success,” he said.

The Future of Cancer Registry Operations

The cutting-edge AI capabilities distinguish Inspirata AI from competitors by employing a tailored approach to various AI technologies. While many solutions rely solely on large language models, Inspirata uses proprietary algorithms and machine learning for developing rapid concept detection and handling complex domain knowledge.

George Cernille, Chief Technology Officer at Inspirata AI, highlighted this unique positioning: “Our approach combines the best aspects of AI with years of oncology-specific engineering. This meticulous attention to detail enhances the application of complex inferencing, allowing us to achieve unprecedented levels of casefinding accuracy.”

By streamlining processes and enhancing functionalities in cancer registry operations, Inspirata AI equips healthcare organizations with the tools needed to drive oncology service advancements, improve patient outcomes, and support informed decision-making at both clinical and business levels. As the company aims to maximize the value of oncology data, it is set to empower cancer programs to eliminate data redundancies, swiftly identify patients, and enhance care across the cancer treatment spectrum.

To explore the transformative capabilities of Inspirata AI and its partnership with ONCO, interested parties can visit their end-to-end cancer registry solution page.

About Inspirata AI

Formerly known as Artificial Intelligence in Medicine (AIM), Inspirata AI is dedicated to providing innovative, real-time solutions for cancer casefinding directly from clinical documentation. Positioned as a leader in the market, the platform's wide-ranging impact is underscored by a long-standing presence in the healthcare sector, trusted by organizations nationwide. By redefining cancer registry management, Inspirata AI helps turn a conventional cost center into a strategic asset for growth and enhanced patient care.